查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1802965

全球 AR恐懼症治療市場：2032 年預測 - 按恐懼症類型、成分、部署方法、最終用戶和地區進行分析

AR Phobia Treatment Market Forecasts to 2032 - Global Analysis By Phobia Type, Component, Deployment Mode, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球 AR恐懼症治療市場預計在 2025 年將達到 1.657 億美元，到 2032 年將達到 5.406 億美元，預測期內的複合年成長率為 18.4%。

擴增實境(AR)恐懼症療法是一種新穎的治療方法，它利用身臨其境型AR 技術，幫助患者在可控的互動環境中面對和應對特定的恐懼症。透過 AR 應用和設備模擬逼真的恐懼場景，患者可以安全、可自訂且經濟高效的方式接受分級暴露療法。這種方法提高了患者的參與度，並減少了傳統療法的局限性，使其在行為健康干預領域越來越受歡迎。

根據美國心理健康研究所（NIMH）的數據，估計有 12.5% 的美國成年人在生命中的某個時刻會經歷特定的恐懼症。

焦慮症和恐懼症盛行率上升

焦慮症和特定恐懼症在全球範圍內的日益普及是這一市場的主要驅動力。盛行率的上升擴大了可及的患者群體，並直接刺激了對創新且便捷的治療方法（例如基於AR的暴露療法）的需求。此外，人們日益成長的心理健康意識正在將這些疾病非人格化，並鼓勵人們尋求治療。此外，AR在創建可控且身臨其境型的治療環境方面已被證實有效，使其成為優於傳統方法的替代方案，並促使其被臨床醫生和醫療保健機構廣泛採用。

實施成本高

AR頭戴裝置的高單位成本以及創建經臨床檢驗的治療內容的費用限制了其在私人診所和小型診所的普及。治療師需要接受專業培訓，這進一步增加了整體擁有成本。這一經濟障礙可能會減緩其普及速度，尤其是在價格敏感型市場和新興市場，並將市場發展限制在資金充足的營運商手中。

擴展到家庭護理和行動醫療應用

開發與行動醫療(行動醫療 ) 應用整合的家庭治療解決方案蘊含著巨大的商機。這項擴展將使治療的可近性更加民主化，並幫助患者克服地理和時間安排的障礙。遠端監控功能使臨床醫生能夠即時監督治療進展並虛擬調整治療通訊協定。此外，智慧型手機和價格實惠的擴增實境/虛擬實境 (AR/VR) 配件的廣泛普及，為提供治療內容、開闢新的收入來源以及促進更持續、以患者為中心的護理模式，創造了一個龐大且可擴展的平台。

資料隱私和安全問題

作業系統是網路攻擊的熱門目標，因為它們會收集高度私密的生物特徵和效能數據。一旦發生資料洩露，可能會嚴重損害醫療服務提供者的聲譽，並削弱患者的信任。此外，遵守複雜且不斷發展的全球醫療資料法規（例如《健康保險流通與責任法案》(HIPAA) 和《一般資料保護規範》(GDPR)），會增加合規負擔和營運複雜性，從而可能阻礙醫療服務提供者和病患的投資和採用。

COVID-19的影響：

新冠疫情顯著加速了AR恐懼症治療市場的發展。封鎖和保持社交距離的規定擾亂了傳統的面對面治療，迫切需要遠距心理健康解決方案。這推動了遠端醫療和數位治療方法的應用，包括基於AR的暴露療法，這些療法可以遠端進行。此外，疫情期間人們對心理健康的關注度不斷提高，也提高了人們對此類創新治療方法的認知和接受度，為疫情後的市場發展提供了持續的動力。

預測期內恐懼症細分市場預計將成為最大的市場

由於全球恐懼症的盛行率高，且擴增實境（AR）技術在其治療中具有出色的適用性，預計在預測期內，恐恐懼症領域將佔據最大的市場佔有率。 AR技術的獨特之處在於，它能夠高度逼真地模擬高海拔環境，且強度可控，使其成為分級暴露療法的基礎。此外，其用於模擬高度變化的清晰且可測量的參數使其成為臨床應用的理想選擇，深受治療師和患者的青睞。

預計在預測期內，雲端基礎的部分將以最高的複合年成長率成長。

預計在預測期內，雲端基礎的細分市場將實現最高成長率，這得益於人們對擴充性、靈活且經濟高效的解決方案的日益偏好，這些解決方案允許患者和醫療保健提供者遠端存取治療平台。雲端基礎的系統可與虛擬和擴增實境工具無縫整合，從而實現個人化治療和即時進度追蹤。此外，遠端醫療服務的日益普及、網際網路普及率的不斷提高以及對遠距心理健康支持的需求也推動了這一趨勢。這些優勢使雲端基礎的細分市場成為擴增實境恐懼症治療解決方案的可近性、效率和整體應用的關鍵驅動力。

比最大的地區

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療基礎設施、高昂的醫療成本以及對創新數位醫療技術的早期採用。該地區領先的市場參與者以及對心理健康的濃厚興趣將進一步推動成長。此外，支持性的法律規範和對數位療法的優惠報銷方案正在推動醫療服務提供者的採用和患者的可及性，從而鞏固北美作為主要收益地區的地位。

複合年成長率最高的地區：

預計亞太地區將在預測期內實現最高的複合年成長率，這得益於其龐大的患者群體、日益成長的精神健康意識以及醫療保健可及性的改善。快速的數位化、不斷提升的智慧型手機普及率以及醫療IT基礎設施投資的不斷增加，為行動醫療和基於擴增實境（AR）的解決方案創造了肥沃的土壤。此外，焦慮症日益加重的負擔以及專注於數位療法的新興企業的興起，帶來了巨大的未開發潛力，使該市場成為成長最快的市場。

成分

  • 軟體
  • 硬體
  • 服務

免費客製化服務

此報告的訂閱者可以從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 簡介

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 主要研究資料
    • 二手研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 市場機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 企業之間的競爭

5.全球AR恐懼症治療市場（按恐懼症類型）

  • 動物恐懼症
  • 恐懼症高症
  • 言語恐懼症
  • 飛行恐懼症
  • 恐懼症
  • 雷聲恐懼症
  • 恐懼症
  • 其他類型的恐懼症

6.全球AR恐懼症治療市場（按組成部分）

  • 軟體
    • AR內容和應用程式
    • 平台/管理軟體
  • 硬體
    • 頭戴式顯示器 (HMD) 和智慧眼鏡
    • 智慧型手機和平板電腦
    • 感測器追蹤器
  • 服務
    • 整合和部署
    • 支援和維護
    • 培訓和諮詢

7.全球AR恐懼症治療市場（依部署方式）

  • 本地
  • 雲端基礎

8.全球AR恐懼症治療市場（按最終用戶）

  • 醫院和診所
  • 治療與諮商中心
  • 家庭用戶/患者
  • 研究和學術機構

9.全球AR恐懼症治療市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併與收購（M&A）
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Limbix
  • Psious
  • BehaVR
  • XRHealth
  • Oxford VR
  • AppliedVR
  • Sanofi
  • Teva Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • Biogen
  • Pear Therapeutics
  • CognifiSense
  • Virtually Better
  • Mimerse
Product Code: SMRC30491

According to Stratistics MRC, the Global AR Phobia Treatment Market is accounted for $165.7 million in 2025 and is expected to reach $540.6 million by 2032 growing at a CAGR of 18.4% during the forecast period. Augmented reality (AR) phobia treatment is an emerging therapeutic approach that leverages immersive AR technologies to help individuals confront and manage specific phobias in controlled, interactive environments. By simulating realistic fear-inducing scenarios through AR applications and devices, patients can undergo gradual exposure therapy in a safe, customizable, and cost-effective manner. This method enhances engagement, reduces traditional therapy limitations, and is increasingly gaining traction in behavioral health interventions.

According to the National Institute of Mental Health (NIMH), an estimated 12.5% of U.S. adults experience a specific phobia at some time in their lives.

Market Dynamics:

Driver:

Rising prevalence of anxiety disorders and phobias

The increasing global incidence of anxiety disorders and specific phobias is a primary driver for this market. This rising prevalence expands the addressable patient population, directly catalyzing demand for innovative and accessible treatment modalities like AR-based exposure therapy. Additionally, growing mental health awareness destigmatizes these conditions, encouraging individuals to seek treatment. Moreover, the proven efficacy of AR in creating controlled, immersive therapeutic environments positions it as a superior alternative to traditional methods, compelling its adoption by clinicians and healthcare institutions.

Restraint:

High implementation costs

The high per-unit cost of AR headsets and the expense of creating clinically validated therapeutic content limit accessibility for individual practitioners and smaller clinics. The need for specialized training for therapists further increases the total cost of ownership. This financial barrier can slow down widespread adoption, particularly in price-sensitive markets and developing regions, potentially restricting market growth to well-funded entities.

Opportunity:

Expansion into home-based treatment and mHealth apps

A significant opportunity lies in the development of home-based treatment solutions integrated with mobile health (mHealth) applications. This expansion democratizes access to therapy, overcoming geographical and scheduling barriers for patients. Remote monitoring capabilities allow clinicians to oversee progress and adjust treatment protocols virtually. Moreover, the proliferation of smartphones and affordable AR/VR accessories creates a vast, scalable platform for delivering therapeutic content, opening new revenue streams and fostering a more continuous and patient-centric care model.

Threat:

Data privacy and security concerns

Operating systems collect highly personal biometric and performance data, making them attractive targets for cyberattacks. Breaches could lead to severe reputational damage for providers and erode patient trust. Moreover, navigating the complex, evolving landscape of global health data regulations, such as HIPAA and GDPR, adds compliance burdens and operational complexity, potentially deterring investment and adoption from both providers and patients.

Covid-19 Impact:

The Covid-19 pandemic significantly accelerated the AR phobia treatment market. Lockdowns and social distancing mandates disrupted traditional in-person therapy, creating an urgent need for remote, accessible mental health solutions. This catalyzed the adoption of telehealth and digital therapeutics, including AR-based exposure therapy, which could be administered remotely. Additionally, the heightened focus on mental wellness during the crisis increased awareness and acceptance of such innovative treatment modalities, providing a sustained boost to market development post-pandemic.

The acrophobia segment is expected to be the largest during the forecast period

The acrophobia segment is expected to account for the largest market share during the forecast period due to the high global prevalence of fear of heights and the exceptional suitability of AR for its treatment. AR technology is uniquely capable of simulating elevated environments with a high degree of realism and controllable intensity, which is fundamental for graduated exposure therapy. Additionally, the clear and measurable parameters for simulating height variations make it an ideal clinical application, driving its preference among therapists and patients alike, thereby securing its dominant market position.

The cloud-based segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cloud-based segment is predicted to witness the highest growth rate, driven by the rising preference for scalable, flexible, and cost-efficient solutions that allow patients and healthcare providers to access treatment platforms remotely. Cloud-based systems offer seamless integration with virtual reality and augmented reality tools, enabling personalized therapy and real-time progress tracking. Additionally, the increasing adoption of telehealth services, growing internet penetration, and demand for remote mental health support are accelerating this trend. These advantages position the cloud-based segment as a key driver in advancing accessibility, efficiency, and overall adoption of AR-based phobia treatment solutions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by its advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative digital health technologies. The presence of leading market players and a strong focus on mental health in the region further propel growth. Additionally, supportive regulatory frameworks and favorable reimbursement scenarios for digital therapeutics encourage both provider adoption and patient access, consolidating North America's position as the dominant revenue-generating region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by a large patient population, increasing awareness of mental health disorders, and improving healthcare accessibility. Rapid digitalization, growing smartphone penetration, and rising investments in healthcare IT infrastructure create fertile ground for mHealth and AR-based solutions. Moreover, the increasing burden of anxiety disorders and a growing number of startups focusing on digital therapeutics present significant untapped potential, making it the fastest-growing market.

Key players in the market

Some of the key players in AR Phobia Treatment Market include Limbix, Psious, BehaVR, XRHealth, Oxford VR, AppliedVR, Sanofi, Teva Pharmaceuticals, Johnson & Johnson, Novartis, Biogen, Pear Therapeutics, CognifiSense, Virtually Better and Mimerse.

Key Developments:

In June 2025, Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, announced results from a study of treatment patterns among patients with tardive dyskinesia residing in long-term care facilities, highlighting a critical gap in TD diagnosis and treatment. Key results from the study revealed: Of the residents being treated with antipsychotic drugs, 5.6% had a diagnosis of extrapyramidal syndrome, - a broad term used to describe any drug-induced movement disorder with no wide-treating therapeutic option - while 1.1% had a specific diagnosis of TD.

In May 2022, Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced four data presentations for AUSTEDO(R) (deutetrabenazine) tablets and TV-46000/mdc-IRM. These data will be presented at the American Psychiatric Association (APA) Annual Meeting held May 21-25, 2022 in New Orleans, Louisiana, and again virtually June 7-10, 2022.

Phobia Types Covered:

  • Zoophobia
  • Acrophobia
  • Glossophobia
  • Aerophobia
  • Claustrophobia
  • Astraphobia
  • Trypanophobia
  • Other Phobia Types

Components:

  • Software
  • Hardware
  • Services

Deployment Modes Covered:

  • On-Premise
  • Cloud-Based

End Users Covered:

  • Hospitals and Clinics
  • Therapy and Counseling Centers
  • Home-based Users / Patients
  • Research and Academic Institutions

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global AR Phobia Treatment Market, By Phobia Type

  • 5.1 Introduction
  • 5.2 Zoophobia
  • 5.3 Acrophobia
  • 5.4 Glossophobia
  • 5.5 Aerophobia
  • 5.6 Claustrophobia
  • 5.7 Astraphobia
  • 5.8 Trypanophobia
  • 5.9 Other Phobia Types

6 Global AR Phobia Treatment Market, By Component

  • 6.1 Introduction
  • 6.2 Software
    • 6.2.1 AR Content & Applications
    • 6.2.2 Platform/Management Software
  • 6.3 Hardware
    • 6.3.1 Head-Mounted Displays (HMDs) & Smart Glasses
    • 6.3.2 Smartphones & Tablets
    • 6.3.3 Sensors & Trackers
  • 6.4 Services
    • 6.4.1 Integration & Deployment
    • 6.4.2 Support & Maintenance
    • 6.4.3 Training & Consulting

7 Global AR Phobia Treatment Market, By Deployment Mode

  • 7.1 Introduction
  • 7.2 On-Premise
  • 7.3 Cloud-Based

8 Global AR Phobia Treatment Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Therapy and Counseling Centers
  • 8.4 Home-based Users / Patients
  • 8.5 Research and Academic Institutions

9 Global AR Phobia Treatment Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Limbix
  • 11.2 Psious
  • 11.3 BehaVR
  • 11.4 XRHealth
  • 11.5 Oxford VR
  • 11.6 AppliedVR
  • 11.7 Sanofi
  • 11.8 Teva Pharmaceuticals
  • 11.9 Johnson & Johnson
  • 11.10 Novartis
  • 11.11 Biogen
  • 11.12 Pear Therapeutics
  • 11.13 CognifiSense
  • 11.14 Virtually Better
  • 11.15 Mimerse

List of Tables

  • Table 1 Global AR Phobia Treatment Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global AR Phobia Treatment Market Outlook, By Phobia Type (2024-2032) ($MN)
  • Table 3 Global AR Phobia Treatment Market Outlook, By Zoophobia (2024-2032) ($MN)
  • Table 4 Global AR Phobia Treatment Market Outlook, By Acrophobia (2024-2032) ($MN)
  • Table 5 Global AR Phobia Treatment Market Outlook, By Glossophobia (2024-2032) ($MN)
  • Table 6 Global AR Phobia Treatment Market Outlook, By Aerophobia (2024-2032) ($MN)
  • Table 7 Global AR Phobia Treatment Market Outlook, By Claustrophobia (2024-2032) ($MN)
  • Table 8 Global AR Phobia Treatment Market Outlook, By Astraphobia (2024-2032) ($MN)
  • Table 9 Global AR Phobia Treatment Market Outlook, By Trypanophobia (2024-2032) ($MN)
  • Table 10 Global AR Phobia Treatment Market Outlook, By Other Phobia Types (2024-2032) ($MN)
  • Table 11 Global AR Phobia Treatment Market Outlook, By Component (2024-2032) ($MN)
  • Table 12 Global AR Phobia Treatment Market Outlook, By Software (2024-2032) ($MN)
  • Table 13 Global AR Phobia Treatment Market Outlook, By AR Content & Applications (2024-2032) ($MN)
  • Table 14 Global AR Phobia Treatment Market Outlook, By Platform/Management Software (2024-2032) ($MN)
  • Table 15 Global AR Phobia Treatment Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 16 Global AR Phobia Treatment Market Outlook, By Head-Mounted Displays (HMDs) & Smart Glasses (2024-2032) ($MN)
  • Table 17 Global AR Phobia Treatment Market Outlook, By Smartphones & Tablets (2024-2032) ($MN)
  • Table 18 Global AR Phobia Treatment Market Outlook, By Sensors & Trackers (2024-2032) ($MN)
  • Table 19 Global AR Phobia Treatment Market Outlook, By Services (2024-2032) ($MN)
  • Table 20 Global AR Phobia Treatment Market Outlook, By Integration & Deployment (2024-2032) ($MN)
  • Table 21 Global AR Phobia Treatment Market Outlook, By Support & Maintenance (2024-2032) ($MN)
  • Table 22 Global AR Phobia Treatment Market Outlook, By Training & Consulting (2024-2032) ($MN)
  • Table 23 Global AR Phobia Treatment Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 24 Global AR Phobia Treatment Market Outlook, By On-Premise (2024-2032) ($MN)
  • Table 25 Global AR Phobia Treatment Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 26 Global AR Phobia Treatment Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global AR Phobia Treatment Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 28 Global AR Phobia Treatment Market Outlook, By Therapy and Counseling Centers (2024-2032) ($MN)
  • Table 29 Global AR Phobia Treatment Market Outlook, By Home-based Users / Patients (2024-2032) ($MN)
  • Table 30 Global AR Phobia Treatment Market Outlook, By Research and Academic Institutions (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.